90TEN picked up the Communiqué Communications Consultancy of the Year at last night’s 2019 Communiqué Awards in London, seeing off competition from GCI, Hanover Health, In
Sanofi is still plugging away with its oral BTK inhibitor tolebrutinib in multiple sclerosis, but has decided to abandon efforts to develop the drug for neuromuscular diso
In the newest episode of the pharmaphorum podcast, editor-in-chief Jonah Comstock speaks with Jameka Hill, senior director of clinical trial health equity at Moderna.